TrialScientific reports2024

A safety evaluation of intermittent high-dose inhaled nitric oxide in viral pneumonia due to COVID-19: a randomised clinical study.

Talya Wolak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.